WellSpan Oncology Research is a clinical research site located in York, Pennsylvania, United States 17403.
Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.
WellSpan Oncology Research has participated in 6 clinical trials with 3 currently active.
Therapeutic areas: Lennox Gastaut Syndrome (LGS), Non-small Cell Lung Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Sponsors: Takeda, Pfizer, Hoffmann-La Roche.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in York
Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
WellSpan Oncology Research has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
WellSpan Oncology Research has 6 clinical trials on record, with 3 currently active. Their work covers Lennox Gastaut Syndrome (LGS), Non-small Cell Lung Cancer, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer.
WellSpan Oncology Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.